10th Annual World Cancer Series Europe

Start:

Mon, 30 Sep 2024, 09:00

End:

Tue, 1 Oct 2024, 18:00

Website:

https://iii.hm/worldcancerseries24

Venue:

Exhibit

Symposia

Workshops

Organiser

Sponsor

Shaping Europe’s cancer-control agenda with technology, data and patient focus

The tenth anniversary of the World Cancer Series will reflect on the achievements in cancer control over the last ten years and look to the future. The next ten years hold the promise of better cancer control, powered by advances in bioscience and technology, and enabled by data-driven insights and the collaboration between humans and AI.

The summit aims to engage with more empowered patients and citizens, contributing effectively to policy and shaping their own care.

A key theme across sessions will be inclusive access to care and better outcomes for all. There are hard challenges ahead: an ageing population, a shrinking workforce, geopolitical instability, and the policy, financing and regulatory challenges posed by the remarkable and accelerating pace of innovation.

These are tough times; but also promising , exciting times. Join the tenth annual World Cancer Series Europe to shape the next ten years of the cancer-control agenda for Europe and create global influence and impact.

The 10th annual World Cancer Series 2024 will take place in Brussels - Marriott Hotel Grand Place on September 30th - October 1st 2024.

Benefits of attending the event

Exclusive speakers - Our commitment to quality and our unique ability to reach C-Suite executives means that we are able to attract the most important, qualified influencers to speak at our events.

Networking - Network with 300+ high-level audience representing policymakers, healthcare providers, industry leaders, academics, patient groups and investors.

Meet with businesses - A strategy-focused event involving the full healthcare ecosystem — rather than just the science.

Practical case studies - Through case studies, interviews and discussions we provide actionable insights and solutions to help cancer stakeholders navigate their strategies.

Cross functional audience - This event will prepare leaders with fresh, focused and thorough content on the latest topics that are high on the policy agenda for cancer care experts and decision-makers: prevention, detection, early-diagnosis, frontiers in treatment and accelerating innovation.

Interactive panels, fireside chats and keynotes - Engage in panel discussions, presentations, roundtables, interviews and more to enable better decisions for your business.

Registration – in-person

In-person passes

Please choose your pass from the options below that best fits your role*

Delegate registration bbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb		Complimentary pass* (limited number available)
Access to all conference sessions on September 30th-1st October 2024 All in-person networking opportunities Light breakfast, lunch and coffee breaks Access to the networking platform 2 weeks before the event to set up meetings Applicable to: All other job titles and job functions.		Access to all conference sessions on September 30th-1st October 2024 Access to the networking platform 2 weeks before the event to set up meetings Light breakfast, lunch and coffee breaks All in-person networking opportunities Applicable to: Government & Ministries, policy makers and healthcare regulatory bodies, patient groups, charities, clinicians, academia/researchers, clinicians, healthcare professionals and providers
€1299.00 Plus VAT		Free
Register Now		Register Now

Agenda 2024
September 30th-1st October 2024

The first day of the programme will begin with plenary sessions focusing on progress from the last decade, current priorities and the road ahead, emphasising the need for data-driven insights and solutions for cancer-control. The two tracks will cover specific cancers and AI and digital applications, with sessions discussing women’s cancers, prostate cancer, how digital technologies are supporting cancer healthcare systems and launching the “innovation showcase” presentations.

The second day of the programme will begin with plenary sessions discussing incremental innovations, the role of private-sector insurance, antimicrobial resistance and patient experiences. The track sessions will focus on diagnostics and treatments, funding cancer care, equity and inclusivity and the future of patient advocacy. The agenda will include extended networking breaks, the expo area and roundtable discussions. The closing plenary workshop will engage the full audience and speakers of the event to map out a path for the future of cancer care and control.